Evidence map›Paper›PMID 31255680›Full record

ArticleBrain, behavior, and immunity2019

CREB deletion increases resilience to stress and downregulates inflammatory gene expression in the hippocampus.

Melissa T Manners, Julia K Brynildsen, Max Schechter, Xin Liu, Darrell Eacret, Julie A Blendy

Open access · greenAbstract read
In one paragraph

Article in Brain, behavior, and immunity, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. The crosstalk between CREB and PER2 mediates the transition between mania- and depression-like behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  5. Article
  6. Effects ofJournal of microbiology and biotechnology · 2025
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Neuroprotective Effects ofAntioxidants (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Melissa T MannersDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Julia K BrynildsenDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Max SchechterDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Xin LiuBiological Basis of Behavior, College of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, United States.
Darrell EacretDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Julie A BlendyDepartment of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States; Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States. Electronic address: blendy@pennmedicine.upenn.edu.
University of Pennsylvania · USTranslational Therapeutics (United States) · US

Funding

T32 Translational Addiction Research Fellowship ProgramT32DA028874 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI Julie A Blendy, Anna Rose Childress · 2010 to 2026
$5.0M
AMP-activated protein kinase (AMPK) and nicotine dependenceR01DA041180 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A, KIM, SANGWON F · 2016 to 2020
$1.8M
Integrative Training in the Neurocircuitry of Affective DisordersT32MH106442 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI SHELINE, YVETTE I · 2016 to 2020
$1.1M
Behavioral and epigenetic changes following adolescent oxycodone exposureR21DA044017 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BLENDY, JULIE A · 2017 to 2018
$443k
NIDA NIH HHS R01 DA041180NIDA NIH HHS R21 DA044017NIDA NIH HHS T32 DA028874NIMH NIH HHS T32 MH106442
6 · The paper itself

Abstract

The transcription factor CREB (cyclic AMP response element (CRE)-binding protein) is implicated in the pathophysiology and treatment of depression. Structural and functional studies in both animals and humans suggest that abnormalities of the hippocampus may play a role in depression. CREB regulates thousands of genes, yet to date, only a handful that mediate depression or antidepressant response have been identified as relevant CREB targets. In order to comprehensively identify genes regulated by CREB in the hippocampus, we employed translating ribosome affinity purification (TRAP) to detect actively translating mRNAs in wild type and CREB-deficient mice. Using Creb

Indexed as

AnimalsAntidepressive AgentsBrainCyclic AMP Response Element-Binding ProteinDepressionGene ExpressionGene Expression RegulationHippocampusInflammationMaleMiceMice, Inbred C57BLMice, KnockoutPhosphorylationStress, PsychologicalTemporal LobeAntidepressive AgentsCreb1 protein, mouseCyclic AMP Response Element-Binding ProteinToll-Like Receptor 1

Identifiers

PMID31255680
PMCPMC6754757
OpenAlexW2954931807

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.